Beam Therapeutics Inc. - 10-Q Filing
Beam Therapeutics reports Q3 2025 financial results including updates on contingent consideration liabilities and financing agreements.
Tickers: $BEAM
Beam Therapeutics reports Q3 2025 financial results including updates on contingent consideration liabilities and financing agreements.
Tickers: $BEAM